06.04.2011 • News

Triton, Rhone Sole Bidders For Evonik Unit

Financial investors Triton Capital and Rhone Group remain the sole bidders for the Carbon Black unit of unlisted German chemical maker Evonik, two people familiar with the transaction told Reuters on Tuesday.

The deal is expected to be signed within the next 10 days and will probably value the unit at about €1 billion ($1.42 billion) including assumed debt, the sources also said.

Evonik and Rhone declined to comment. Triton was not immediately available for comment.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

most read